Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Voice box transplant trial hopes to give speech back to patients

NCT ID NCT03269396

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused This study
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jul 23, 2026 · Updated 2 times

Summary

This study tests whether transplanting a donor voice box (larynx) can safely restore voice, swallowing, and breathing in people with severe larynx damage or who have had their larynx removed. Ten adults will receive the transplant and be followed for five years. The trial is currently on hold.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
larynx allograft (donor voice box)
What this could lead to
If successful, this could offer a way to restore natural voice, swallowing, and breathing for people who have lost larynx function due to injury or surgery.
What could go wrong
This is a very early, small study (10 people) that is currently suspended. The procedure carries major risks, including rejection of the transplant and the need for lifelong immune-suppressing drugs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 10 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2023

Expected to finish

May 2033

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Potential subjects for this study include patients with severe laryngeal dysfunction or a previous laryngectomy. For the purposes of this study, severe laryngeal dysfunction is defined as the loss of normal laryngeal function resulting in significant dysphonia, dysphagia, or dyspnea. Inclusion Criteria: * Ages 18 years and older * Male or Female * One of the following: * Severe laryngeal dysfunction as described above * Laryngeal stenosis * 5 years or longer s/p definitive management for head and neck cancer * Laryngeal cancer requiring total laryngectomy in a patient already on immunosuppression * Low-grade chondrosarcoma requiring total laryngectomy * Ability to obtain informed consent from the patient Exclusion Criteria: Poor surgical candidacy secondary to poor physical/mental health as determined by a pre-operative medical evaluation General medical status * Pregnancy * Any systemic disease which would alter life expectancy * Active neoplastic disease, not considered yet to be cured (Exceptional cases will be considered in case by case discussion)Less than 5 years s/p definitive management for cancer * Cancer within the last 5 years (Exceptional cases will be considered in case by case discussion) * Obesity (Body Mass Index \>29 - 30)(Exceptional cases will be considered on a case by case basis) * Cachexia (BMI\<18)(Exceptional cases will be considered on a case by case basis) Significant renal dysfunction (Creatinine clearance \< 50 ml/min.) * Significant hepatic dysfunction * Significant kidney damage * Unmanageable infections * Unable to participate in preoperative exercise training * Unable to be weaned to equal or less than 10 mg/day of steroids * Untreatable cardiac disease * Active neuromuscular disease * History of recurrent aspiration or active, unmanageable Gastro-Esophageal Reflux * Patients with active connective tissue diseases (exceptions to be considered in a case by case basis) * Patients unable to achieve \> 600 feet in a 6 minute walk test (exceptions to be considered in a case by case basis) * Patients considered having active immunodeficiency disorders (exceptions to be considered in a case by case basis) * Multiple co-morbidities that would make transplantation prohibitively risky * Psychosocial parameters * Severe mental retardation, psychosis, depression or organic brain syndrome * Uncontrolled diabetes mellitus. Once HbA1C \< 7, reevaluate for candidacy. * Active substance use within 6 months * Active smoking within 6 months * Active alcoholism within 6 months * Inability to comply with transplant-related management and medical follow-up * Any other circumstances that deem the candidate high risk from a psychosocial perspective

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Laryngeal cancer requiring total laryngectomy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Mayo Clinic in Arizona

    Phoenix, Arizona, 85054, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.